NCT06674759View on ClinicalTrials.gov

Efficacy and Safety of Tongren-Dahuoluo Bolus in Patients with Knee Osteoarthritis

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

January 10, 2025

Primary Completion Date

June 30, 2025

Study Completion Date

December 30, 2025

Conditions
Knee Osteoarthritis (Knee OA)
Interventions
DRUG

Tongren-Dahuoluo Bolus

0.72g,2 times a day, oral, for 24 weeks.

DRUG

Tongren-Dahuoluo Bolus Placebo

0.72g,2 times a day, oral, for 12 weeks.

All Listed Sponsors
lead

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

OTHER